Home HIV	FAQ My Amedeo About	Flying Publisher
	Amedeo Prize 2008 The 21 Finalists

Prostate Cancer

Free Subscription Articles published in J Urol Retrieve available abstracts of 307 articles: HTML format

Single Articles

May 2008
1. CHROUSER K , Leibovich B, Bergstralh E, Zincke H, et al
   Bladder cancer risk following primary and adjuvant external beam radiation for prostate cancer.
   J Urol. 2008;179.
   PubMed     Related articles    Abstract available
   
   
   
2. MOUL JW , Wu H, Sun L, McLeod DG, et al
   Early versus delayed hormonal therapy for prostate specific antigen only recurrence of prostate cancer after radical prostatectomy.
   J Urol. 2008;179.
   PubMed     Related articles    Abstract available
   
   
   
3. PENSON DF , McLerran D, Feng Z, Li L, et al
   5-year urinary and sexual outcomes after radical prostatectomy: results from the Prostate Cancer Outcomes Study.
   J Urol. 2008;179.
   PubMed     Related articles    Abstract available
   
   
   
4. CROOK J
   Commentary on prostate brachytherapy for localized prostate cancer.
   J Urol. 2008;179.
   PubMed     Related articles   
   
   
   
5. POTTERS L , Morgenstern C, Calugaru E, Fearn P, et al
   12-year outcomes following permanent prostate brachytherapy in patients with clinically localized prostate cancer.
   J Urol. 2008;179.
   PubMed     Related articles    Abstract available
   
   
   
6. STROPE SA , Hollenbeck BK
   Commentary on watchful waiting and health related quality of life for patients with localized prostate cancer.
   J Urol. 2008;179.
   PubMed     Related articles   
   
   
   
7. ARREDONDO SA , Downs TM, Lubeck DP, Pasta DJ, et al
   Watchful waiting and health related quality of life for patients with localized prostate cancer: data from CaPSURE.
   J Urol. 2008;179.
   PubMed     Related articles    Abstract available
   
   
   April 2008
8. BENNETT JK , Foote J, Alphonse P, Hood N, et al
   Re: Obesity and Prostate Cancer: Importance of Race and Stage of Disease S. J. Freedland J Urol 2007; 178: 1842-1843.
   J Urol. 2008;179:2481-2482.
   PubMed     Related articles   
   
   
   
9. SVATEK RS , Shulman MJ, Benaim EA, Rogers TE, et al
   Change in Prostate Specific Antigen Following Androgen Stimulation is an Independent Predictor of Prostate Cancer Diagnosis.
   J Urol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
10. HELFAND BT , Loeb S, Cashy J, Meeks JJ, et al
    Tumor Characteristics of Carriers and Noncarriers of the deCODE 8q24 Prostate Cancer Susceptibility Alleles.
    J Urol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
11. DAVIS JW , Nakanishi H, Kumar VS, Bhadkamkar VA, et al
    Circulating Tumor Cells in Peripheral Blood Samples From Patients With Increased Serum Prostate Specific Antigen: Initial Results in Early Prostate Cancer.
    J Urol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
12. HALAT SK , MacLennan GT
    Adenoid cystic/basal cell carcinoma of the prostate.
    J Urol. 2008;179:1576.
    PubMed     Related articles   
    
    
    
13. HALTER RJ , Schned A, Heaney J, Hartov A, et al
    Electrical impedance spectroscopy of benign and malignant prostatic tissues.
    J Urol. 2008;179:1580-6.
    PubMed     Related articles    Abstract available
    
    
    
14. DERAS IL , Aubin SM, Blase A, Day JR, et al
    PCA3: a molecular urine assay for predicting prostate biopsy outcome.
    J Urol. 2008;179:1587-92.
    PubMed     Related articles    Abstract available
    
    
    
15. SHARIAT SF , Walz J, Roehrborn CG, Montorsi F, et al
    Early postoperative plasma transforming growth factor-beta1 is a strong predictor of biochemical progression after radical prostatectomy.
    J Urol. 2008;179:1593-7.
    PubMed     Related articles    Abstract available
    
    
    
16. FINE SW , Epstein JI
    A contemporary study correlating prostate needle biopsy and radical prostatectomy Gleason score.
    J Urol. 2008;179:1335-8.
    PubMed     Related articles    Abstract available
    
    
    
17. THOMPSON RH , Leibovich BC, Karnes RJ, Bergstralh EJ, et al
    Radical retropubic prostatectomy in immunosuppressed transplant recipients.
    J Urol. 2008;179:1349-52.
    PubMed     Related articles    Abstract available
    
    
    
18. BOORJIAN SA , Karnes RJ, Rangel LJ, Bergstralh EJ, et al
    Mayo Clinic validation of the D'amico risk group classification for predicting survival following radical prostatectomy.
    J Urol. 2008;179:1354-60.
    PubMed     Related articles    Abstract available
    
    
    
19. NEILL MG , Toi A, Lockwood GA, Evans A, et al
    Systematic lateral prostate biopsy--are the benefits worth the costs?
    J Urol. 2008;179:1321-6.
    PubMed     Related articles    Abstract available
    
    
    
20. SCATTONI V , Roscigno M, Raber M, Deho F, et al
    Initial extended transrectal prostate biopsy--are more prostate cancers detected with 18 cores than with 12 cores?
    J Urol. 2008;179:1327-31.
    PubMed     Related articles    Abstract available
    
    
    
21. LARSON BT , Magi-Galluzzi C, Casey G, Plummer SJ, et al
    Pathological aggressiveness of prostatic carcinomas related to RNASEL R462Q allelic variants.
    J Urol. 2008;179:1344-8.
    PubMed     Related articles    Abstract available
    
    
    March 2008
22. HIRATA H , Hinoda Y, Kawamoto K, Kikuno N, et al
    Mismatch Repair Gene MSH3 Polymorphism is Associated With the Risk of Sporadic Prostate Cancer.
    J Urol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
23. NAKANISHI H , Groskopf J, Fritsche HA, Bhadkamkar V, et al
    PCA3 Molecular Urine Assay Correlates With Prostate Cancer Tumor Volume: Implication in Selecting Candidates for Active Surveillance.
    J Urol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
24. PATEL MI , Kurek C, Dong Q
    The Arachidonic Acid Pathway and its Role in Prostate Cancer Development and Progression.
    J Urol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
25. KONETY BR , Cowan JE, Carroll PR
    Patterns of Primary and Secondary Therapy for Prostate Cancer in Elderly Men: Analysis of Data From CaPSURE((R)).
    J Urol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
26. SIM HG , Telesca D, Culp SH, Ellis WJ, et al
    Tertiary Gleason Pattern 5 in Gleason 7 Prostate Cancer Predicts Pathological Stage and Biochemical Recurrence.
    J Urol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
27. KATTAN MW
    Predicting Prostate Cancer Behavior-What is a Urologist to Do?
    J Urol. 2008;.
    PubMed     Related articles   
    
    
    
28. RHODEN EL , Riedner CE, Morgentaler A
    The Ratio of Serum Testosterone-to-Prostate Specific Antigen Predicts Prostate Cancer in Hypogonadal Men.
    J Urol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
29. CHOUEIRI TK , Dreicer R, Paciorek A, Carroll PR, et al
    A model that predicts the probability of positive imaging in prostate cancer cases with biochemical failure after initial definitive local therapy.
    J Urol. 2008;179:906-10.
    PubMed     Related articles    Abstract available
    
    
    
30. PAVLOVICH CP , Trock BJ, Sulman A, Wagner AA, et al
    3-year actuarial biochemical recurrence-free survival following laparoscopic radical prostatectomy: experience from a tertiary referral center in the United States.
    J Urol. 2008;179:917-21.
    PubMed     Related articles    Abstract available
    
    
    
31. MUSCH M , Klevecka V, Roggenbuck U, Kroepfl D, et al
    Complications of pelvic lymphadenectomy in 1,380 patients undergoing radical retropubic prostatectomy between 1993 and 2006.
    J Urol. 2008;179:923-8.
    PubMed     Related articles    Abstract available
    
    
    February 2008
32. MEEKS JJ , Thaxton CS, Loeb S, Roehl KA, et al
    Comparison of Prostate Specific Antigen Velocity in Screened Versus Referred Patients With Prostate Cancer.
    J Urol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
33. AL-GHAMDI AM , Lockwood G, Toi A, Kulkarni GS, et al
    Extended Pattern Prostate Biopsy Does Not Minimize the Volume-Grade Bias in Prostate Cancer Detection.
    J Urol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
34. ZELEFSKY MJ , Reuter VE, Fuks Z, Scardino P, et al
    Influence of Local Tumor Control on Distant Metastases and Cancer Related Mortality After External Beam Radiotherapy for Prostate Cancer.
    J Urol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
35. VAN DE POLL-FRANSE LV , Kwan L, Reiter RE, Lee SP, et al
    The Influence of Cardiovascular Disease on Health Related Quality of Life in Men With Prostate Cancer: A 4-Year Followup Study.
    J Urol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
36. TINDALL DJ , Rittmaster RS
    The Rationale for Inhibiting 5alpha-Reductase Isoenzymes in the Prevention and Treatment of Prostate Cancer.
    J Urol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
37. TURLEY RS , Hamilton RJ, Terris MK, Kane CJ, et al
    Small transrectal ultrasound volume predicts clinically significant Gleason score upgrading after radical prostatectomy: results from the SEARCH database.
    J Urol. 2008;179:523-7.
    PubMed     Related articles    Abstract available
    
    
    
38. WHITTEMORE DE , Hick EJ, Carter MR, Moul JW, et al
    Significance of tertiary Gleason pattern 5 in Gleason score 7 radical prostatectomy specimens.
    J Urol. 2008;179:516-22.
    PubMed     Related articles    Abstract available
    
    
    
39. RAVERY V , Dominique S, Panhard X, Toublanc M, et al
    The 20-core prostate biopsy protocol--a new gold standard?
    J Urol. 2008;179:504-7.
    PubMed     Related articles    Abstract available
    
    
    
40. RODRIGUEZ E JR , Skarecky D, Narula N, Ahlering TE, et al
    Prostate volume estimation using the ellipsoid formula consistently underestimates actual gland size.
    J Urol. 2008;179:501-3.
    PubMed     Related articles    Abstract available
    
    
    January 2008
41. SENGUPTA S , Amling C, D'Amico AV, Blute ML, et al
    Prostate Specific Antigen Kinetics in the Management of Prostate Cancer.
    J Urol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
42. SHERIDAN TB , Carter HB, Wang W, Landis PB, et al
    Change in Prostate Cancer Grade Over Time in Men Followed Expectantly for Stage T1c Disease.
    J Urol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
43. YIN M , Bastacky S, Chandran U, Becich MJ, et al
    Prevalence of Incidental Prostate Cancer in the General Population: A Study of Healthy Organ Donors.
    J Urol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
44. FRIEDMAN J , Dunn RL, Wood D, Vaishampayan U, et al
    Neoadjuvant Docetaxel and Capecitabine in Patients With High Risk Prostate Cancer.
    J Urol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
45. DONG F , Jones JS, Stephenson AJ, Magi-Galluzzi C, et al
    Prostate Cancer Volume at Biopsy Predicts Clinically Significant Upgrading.
    J Urol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
46. LEE IH , Sadetsky N, Carroll PR, Sandler HM, et al
    The Impact of Treatment Choice for Localized Prostate Cancer on Response to Phosphodiesterase Inhibitors.
    J Urol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
47. NAMIKI S , Kwan L, Kagawa-Singer M, Saito S, et al
    Sexual function reported by Japanese and American men.
    J Urol. 2008;179:245-9.
    PubMed     Related articles    Abstract available
    
    
    
48. SHAH JB , McKiernan JM, Elkin EP, Carroll PR, et al
    Prostate biopsy patterns in the CaPSURE database: evolution with time and impact on outcome after prostatectomy.
    J Urol. 2008;179:136-40.
    PubMed     Related articles    Abstract available
    
    
    
49. BUSCHEMEYER WC 3RD , Hamilton RJ, Aronson WJ, Presti JC Jr, et al
    Is a positive bladder neck margin truly a T4 lesion in the prostate specific antigen era? Results from the SEARCH Database.
    J Urol. 2008;179:124-9.
    PubMed     Related articles    Abstract available
    
    
    
50. MAGERA JS JR , Inman BA, Slezak JM, Bagniewski SM, et al
    Increased optical magnification from 2.5x to 4.3x with technical modification lowers the positive margin rate in open radical retropubic prostatectomy.
    J Urol. 2008;179:130-5.
    PubMed     Related articles    Abstract available
    
    
    
51. BOUCHELOUCHE K , Oehr P
    Positron emission tomography and positron emission tomography/computerized tomography of urological malignancies: an update review.
    J Urol. 2008;179:34-45.
    PubMed     Related articles    Abstract available
    
    
    
52. CROOK J , Fleshner N, Roberts C, Pond G, et al
    Long-term urinary sequelae following 125iodine prostate brachytherapy.
    J Urol. 2008;179:141-5.
    PubMed     Related articles    Abstract available
    
    
    December 2007
53. JOSEPH JV , Greene T
    Re: Standard Versus Limited Pelvic Lymph Node Dissection for Prostate Cancer in Patients With a Predicted Probability of Nodal Metastasis Greater Than 1% K. Touijer, F. Rabbani, J. R. Otero, F. P. Secin, J. A. Eastham, P. T. Scardino and B. GuillonneauJ
    J Urol. 2007;.
    PubMed     Related articles   
    
    
    
54. STERN JM , Stanfield J, Kabbani W, Hsieh JT, et al
    Selective Prostate Cancer Thermal Ablation With Laser Activated Gold Nanoshells.
    J Urol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
55. BRAND TC , Bermejo C, Canby-Hagino E, Troyer DA, et al
    Association of Polymorphisms in TGFB1 and Prostate Cancer Prognosis.
    J Urol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
56. WOODSON K , O'Reilly KJ, Hanson JC, Nelson D, et al
    The Usefulness of the Detection of GSTP1 Methylation in Urine as a Biomarker in the Diagnosis of Prostate Cancer.
    J Urol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
57. BASTIAN PJ , Palapattu GS, Yegnasubramanian S, Rogers CG, et al
    CpG Island Hypermethylation Profile in the Serum of Men With Clinically Localized and Hormone Refractory Metastatic Prostate Cancer.
    J Urol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
58. WAGNER M , Sokoloff M, Daneshmand S
    The Role of Pelvic Lymphadenectomy for Prostate Cancer-Therapeutic?
    J Urol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
59. ISRAELI RS , Ryan CW, Jung LL
    Managing Bone Loss in Men With Locally Advanced Prostate Cancer Receiving Androgen Deprivation Therapy.
    J Urol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
60. SMITH JA JR , Chan RC, Chang SS, Herrell SD, et al
    A comparison of the incidence and location of positive surgical margins in robotic assisted laparoscopic radical prostatectomy and open retropubic radical prostatectomy.
    J Urol. 2007;178:2385-9.
    PubMed     Related articles    Abstract available
    
    
    
61. LOEB S , Roehl KA, Nadler RB, Yu X, et al
    Prostate specific antigen velocity in men with total prostate specific antigen less than 4 ng/ml.
    J Urol. 2007;178:2348-52.
    PubMed     Related articles    Abstract available
    
    
    
62. SLOVA D , Lepor H
    The short-term and long-term effects of radical prostatectomy on lower urinary tract symptoms.
    J Urol. 2007;178:2397-400.
    PubMed     Related articles    Abstract available
    
    
    
63. LINDEN RA , Trabulsi EJ, Forsberg F, Gittens PR, et al
    Contrast enhanced ultrasound flash replenishment method for directed prostate biopsies.
    J Urol. 2007;178:2354-8.
    PubMed     Related articles    Abstract available
    
    
    
64. PANTUCK AJ , Baniel J, Kirkali Z, Klatte T, et al
    A novel resectoscope for transurethral resection of bladder tumors and the prostate.
    J Urol. 2007;178:2331-6.
    PubMed     Related articles    Abstract available
    
    
    
65. KOCH MO
    Positive margins in urological oncology.
    J Urol. 2007;178:2249.
    PubMed     Related articles   
    
    
    November 2007
66. SMITH MR , Malkowicz SB, Chu F, Forrest J, et al
    Toremifene Increases Bone Mineral Density in Men Receiving Androgen Deprivation Therapy for Prostate Cancer: Interim Analysis of a Multicenter Phase 3 Clinical Study.
    J Urol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
67. MAKAROV DV , Humphreys EB, Mangold LA, Carducci MA, et al
    The Natural History of Men Treated With Deferred Androgen Deprivation Therapy in Whom Metastatic Prostate Cancer Developed Following Radical Prostatectomy.
    J Urol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
68. BOSTROM PJ , Soloway MS, Manoharan M, Ayyathurai R, et al
    Bladder Cancer After Radiotherapy for Prostate Cancer: Detailed Analysis of Pathological Features and Outcome After Radical Cystectomy.
    J Urol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
69. ROBINSON D , Sandblom G, Johansson R, Garmo H, et al
    Prediction of Survival of Metastatic Prostate Cancer Based on Early Serial Measurements of Prostate Specific Antigen and Alkaline Phosphatase.
    J Urol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
70. THOMAS LN , Douglas RC, Lazier CB, Gupta R, et al
    Levels of 5alpha-Reductase Type 1 and Type 2 are Increased in Localized High Grade Compared to Low Grade Prostate Cancer.
    J Urol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
71. JEONG G , Lee KH
    Percent Free Prostate Specific Antigen Does Not Enhance the Specificity of Total Prostate Specific Antigen for the Detection of Prostate Cancer in Korean Men 50 to 65 Years Old: A Prospective Multicenter Study.
    J Urol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
72. GOFRIT ON , Zorn KC, Taxy JB, Lin S, et al
    Predicting the risk of patients with biopsy Gleason score 6 to harbor a higher grade cancer.
    J Urol. 2007;178:1925-8.
    PubMed     Related articles    Abstract available
    
    
    
73. MAGHELI A , Rais-Bahrami S, Humphreys EB, Peck HJ, et al
    Impact of patient age on biochemical recurrence rates following radical prostatectomy.
    J Urol. 2007;178:1933-7.
    PubMed     Related articles    Abstract available
    
    
    
74. MAY M , Knoll N, Siegsmund M, Fahlenkamp D, et al
    Validity of the CAPRA score to predict biochemical recurrence-free survival after radical prostatectomy. Results from a european multicenter survey of 1,296 patients.
    J Urol. 2007;178:1957-62.
    PubMed     Related articles    Abstract available
    
    
    
75. PEDDADA AV , Jennings SB, Faricy PO, Walsh RA 3rd, et al
    Low morbidity following high dose rate brachytherapy in the setting of prior transurethral prostate resection.
    J Urol. 2007;178:1963-7.
    PubMed     Related articles    Abstract available
    
    
    
76. NURANI R , Wallner K, Merrick G, Virgin J, et al
    Optimized prostate brachytherapy minimizes the prognostic impact of percent of biopsy cores involved with adenocarcinoma.
    J Urol. 2007;178:1968-73.
    PubMed     Related articles    Abstract available
    
    
    October 2007
77. TELOKEN PE , Ohebshalom M, Mohideen N, Mulhall JP, et al
    Analysis of the Impact of Androgen Deprivation Therapy on Sildenafil Citrate Response Following Radiation Therapy for Prostate Cancer.
    J Urol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
78. MORRIS MJ , Kelly WK, Slovin S, Ryan C, et al
    A Phase II Trial of Bortezomib and Prednisone for Castration Resistant Metastatic Prostate Cancer.
    J Urol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
79. PAREKH DJ , Ankerst DP, Troyer D, Srivastava S, et al
    Biomarkers for Prostate Cancer Detection.
    J Urol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
80. RYAN CJ , Weinberg V, Rosenberg J, Fong L, et al
    Phase II Study of Ketoconazole Plus Granulocyte-Macrophage Colony-Stimulating Factor for Prostate Cancer: Effect of Extent of Disease on Outcome.
    J Urol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
81. EGGENER SE , Scardino PT, Carroll PR, Zelefsky MJ, et al
    Focal Therapy for Localized Prostate Cancer: A Critical Appraisal of Rationale and Modalities.
    J Urol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
82. KOSITSAWAT J , Flanigan RC, Meydani M, Choi YK, et al
    The Ratio of Oleic-to-Stearic Acid in the Prostate Predicts Biochemical Failure After Radical Prostatectomy for Localized Prostate Cancer.
    J Urol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
83. CARTER HB , Kettermann A, Warlick C, Metter EJ, et al
    Expectant Management of Prostate Cancer With Curative Intent: An Update of The Johns Hopkins Experience.
    J Urol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
84. KOCH MO , Gardner T, Cheng L, Fedewa RJ, et al
    Phase I/II Trial of High Intensity Focused Ultrasound for the Treatment of Previously Untreated Localized Prostate Cancer.
    J Urol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
85. MAGERA JS JR , Inman BA, Elliott DS
    Does preoperative topical antimicrobial scrub reduce positive surgical site culture rates in men undergoing artificial urinary sphincter placement?
    J Urol. 2007;178.
    PubMed     Related articles    Abstract available
    
    
    
86. CHUANG AY , Nielsen ME, Hernandez DJ, Walsh PC, et al
    The significance of positive surgical margin in areas of capsular incision in otherwise organ confined disease at radical prostatectomy.
    J Urol. 2007;178.
    PubMed     Related articles    Abstract available
    
    
    
87. FINLEY DS , Rodriguez E Jr, Ahlering TE
    Combined inguinal hernia repair with prosthetic mesh during transperitoneal robot assisted laparoscopic radical prostatectomy: a 4-year experience.
    J Urol. 2007;178.
    PubMed     Related articles    Abstract available
    
    
    
88. SUBA EJ , Pfeifer JD, Raab SS
    Patient identification error among prostate needle core biopsy specimens--are we ready for a DNA time-out?
    J Urol. 2007;178.
    PubMed     Related articles    Abstract available
    
    
    
89. NG CK , Moussa M, Downey DB, Chin JL, et al
    Salvage cryoablation of the prostate: followup and analysis of predictive factors for outcome.
    J Urol. 2007;178.
    PubMed     Related articles    Abstract available
    
    
    
90. WOOD HM , Reuther AM, Gilligan TD, Kupelian PA, et al
    Rates of biochemical remission remain higher in black men compared to white men after radical prostatectomy despite similar trends in prostate specific antigen induced stage migration.
    J Urol. 2007;178.
    PubMed     Related articles    Abstract available
    
    
    
91. SCHELLHAMMER PF , Diaz JI, Fabrizio MD, Davis JW, et al
    Computer modeling technology to assess extracapsular tissue coverage of whole mount sections after retropubic and laparoscopic radical prostatectomy.
    J Urol. 2007;178.
    PubMed     Related articles    Abstract available
    
    
    
92. ABBOD MF , Catto JW, Linkens DA, Hamdy FC, et al
    Application of artificial intelligence to the management of urological cancer.
    J Urol. 2007;178.
    PubMed     Related articles    Abstract available
    
    
    
93. MAGHELI A , Rais-Bahrami S, Peck HJ, Walsh PC, et al
    Importance of tumor location in patients with high preoperative prostate specific antigen levels (greater than 20 ng/ml) treated with radical prostatectomy.
    J Urol. 2007;178.
    PubMed     Related articles    Abstract available
    
    
    September 2007
94. HARRIS AM , Warner BW, Wilson JM, Becker A, et al
    Effect of alpha1-Adrenoceptor Antagonist Exposure on Prostate Cancer Incidence: An Observational Cohort Study.
    J Urol. 2007;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
95. TRACHTENBERG J , Bogaards A, Weersink RA, Haider MA, et al
    Vascular Targeted Photodynamic Therapy With Palladium-Bacteriopheophorbide Photosensitizer for Recurrent Prostate Cancer Following Definitive Radiation Therapy: Assessment of Safety and Treatment Response.
    J Urol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
96. FREEDLAND SJ
    Obesity and Prostate Cancer: Importance of Race and Stage of Disease.
    J Urol. 2007;.
    PubMed     Related articles   
    
    
    
97. HUANG X , Zhang X, Farahvash B, Olumi AF, et al
    Novel Targeted Pro-Apoptotic Agents for the Treatment of Prostate Cancer.
    J Urol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
98. GIRI VN , Beebe-Dimmer J, Buyyounouski M, Konski A, et al
    Prostate Cancer Risk Assessment Program: A 10-Year Update of Cancer Detection.
    J Urol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
99. REED A , Ankerst DP, Pollock BH, Thompson IM, et al
    Current Age and Race Adjusted Prostate Specific Antigen Threshold Values Delay Diagnosis of High Grade Prostate Cancer.
    J Urol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
100. SPANGLER E , Zeigler-Johnson CM, Coomes M, Malkowicz SB, et al
     Association of Obesity With Tumor Characteristics and Treatment Failure of Prostate Cancer in African-American and European American Men.
     J Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
101. MONTGOMERY RB , Goldman B, Tangen CM, Hussain M, et al
     Association of Body Mass Index With Response and Survival in Men With Metastatic Prostate Cancer: Southwest Oncology Group Trials 8894 and 9916.
     J Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
102. JOHNSTONE PA , Riffenburgh RH, Rossi PJ, Assikis V, et al
     Applying Population Dynamics Modeling to Patients With Lymph Node Positive Prostate Cancer.
     J Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
103. SAJADI KP , Terris MK, Hamilton RJ, Cullen J, et al
     Body mass index, prostate weight and transrectal ultrasound prostate volume accuracy.
     J Urol. 2007;178.
     PubMed     Related articles    Abstract available
     
     
     
104. NICKEL JC , Roehrborn CG, O'leary MP, Bostwick DG, et al
     Examination of the relationship between symptoms of prostatitis and histological inflammation: baseline data from the REDUCE chemoprevention trial.
     J Urol. 2007;178.
     PubMed     Related articles    Abstract available
     
     
     
105. GRIFFIN CR , Yu X, Loeb S, Desireddi VN, et al
     Pathological features after radical prostatectomy in potential candidates for active monitoring.
     J Urol. 2007;178.
     PubMed     Related articles    Abstract available
     
     
     
106. MILLER J , Smith A, Kouba E, Wallen E, et al
     Prospective evaluation of short-term impact and recovery of health related quality of life in men undergoing robotic assisted laparoscopic radical prostatectomy versus open radical prostatectomy.
     J Urol. 2007;178.
     PubMed     Related articles    Abstract available
     
     
     
107. SANDLER HM , Eisenberger MA
     Assessing and treating patients with increasing prostate specific antigen following radical prostatectomy.
     J Urol. 2007;178.
     PubMed     Related articles    Abstract available
     
     
     August 2007
108. ARLEN PM , Skarupa L, Pazdur M, Seetharam M, et al
     Clinical Safety of a Viral Vector Based Prostate Cancer Vaccine Strategy.
     J Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
109. SHAO TC , Li H, Ittmann M, Cunningham GR, et al
     Effects of Dutasteride on Prostate Growth in the Large Probasin-Large T Antigen Mouse Model of Prostate Cancer.
     J Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
110. WILLIAMS CR , Tabios R, Linehan WM, Neckers L, et al
     Intratumor Injection of the Hsp90 Inhibitor 17AAG Decreases Tumor Growth and Induces Apoptosis in a Prostate Cancer Xenograft Model.
     J Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
111. KRUPSKI TL , Foley KA, Baser O, Long S, et al
     Health Care Cost Associated With Prostate Cancer, Androgen Deprivation Therapy and Bone Complications.
     J Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
112. BAHNSON R
     Androgen Deprivation Therapy for Prostate Cancer.
     J Urol. 2007;.
     PubMed     Related articles   
     
     
     
113. MOROTE J , Orsola A, Planas J, Trilla E, et al
     Redefining Clinically Significant Castration Levels in Patients With Prostate Cancer Receiving Continuous Androgen Deprivation Therapy.
     J Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
114. SCALES CD JR , Presti JC Jr, Kane CJ, Terris MK, et al
     Predicting Unilateral Prostate Cancer Based on Biopsy Features: Implications for Focal Ablative Therapy-Results From the SEARCH Database.
     J Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
115. MAGHELI A , Rais-Bahrami S, Carter HB, Peck HJ, et al
     Subclassification of Clinical Stage T1 Prostate Cancer: Impact on Biochemical Recurrence Following Radical Prostatectomy.
     J Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
116. SHARIAT SF , Park S, Trinh QD, Roehrborn CG, et al
     Plasminogen Activation Inhibitor-1 Improves the Predictive Accuracy of Prostate Cancer Nomograms.
     J Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
117. YOSSEPOWITCH O , Pinchuk I, Gur U, Neumann A, et al
     Advanced but Not Localized Prostate Cancer is Associated With Increased Oxidative Stress.
     J Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
118. ITO K , Yamamoto T, Miyakubo M, Takechi H, et al
     Lead Time of Prostate Cancer Detected in Population Based Screening for Prostate Cancer in Japan.
     J Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
119. FILION E , Taussky D, Bahary JP, Maugard CM, et al
     Higher Frequency of Familial Clustering of Prostate Cancer in French-Canadian Men.
     J Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
120. NISHIYAMA T , Ikarashi T, Hashimoto Y, Wako K, et al
     The Change in the Dihydrotestosterone Level in the Prostate Before and After Androgen Deprivation Therapy in Connection With Prostate Cancer Aggressiveness Using the Gleason Score.
     J Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
121. MIEDLER JD , Maclennan GT
     Leiomyosarcoma of the prostate.
     J Urol. 2007;178:668.
     PubMed     Related articles   
     
     
     
122. PATEL AR , Jones JS
     The prostate needle biopsy gun: busting a myth.
     J Urol. 2007;178:683-5.
     PubMed     Related articles    Abstract available
     
     
     
123. GONTERO P , Galzerano M, Bartoletti R, Magnani C, et al
     New insights into the pathogenesis of penile shortening after radical prostatectomy and the role of postoperative sexual function.
     J Urol. 2007;178:602-7.
     PubMed     Related articles    Abstract available
     
     
     
124. HONG SK , Han BK, Jeong SJ, Byun SS, et al
     Effect of statin therapy on early return of potency after nerve sparing radical retropubic prostatectomy.
     J Urol. 2007;178:613-6.
     PubMed     Related articles    Abstract available
     
     
     
125. JAFFE J , Stakhovsky O, Cathelineau X, Barret E, et al
     Surgical outcomes for men undergoing laparoscopic radical prostatectomy after transurethral resection of the prostate.
     J Urol. 2007;178:483-7.
     PubMed     Related articles    Abstract available
     
     
     
126. ROZET F , Jaffe J, Braud G, Harmon J, et al
     A direct comparison of robotic assisted versus pure laparoscopic radical prostatectomy: a single institution experience.
     J Urol. 2007;178:478-82.
     PubMed     Related articles    Abstract available
     
     
     
127. YEE DS , Ahlering TE
     Radical prostatectomy: a current perspective.
     J Urol. 2007;178:376-7.
     PubMed     Related articles   
     
     
     
128. MITTERBERGER M , Pinggera GM, Horninger W, Bartsch G, et al
     Comparison of contrast enhanced color Doppler targeted biopsy to conventional systematic biopsy: impact on Gleason score.
     J Urol. 2007;178:464-8.
     PubMed     Related articles    Abstract available
     
     
     
129. KUBLER HR , Tseng TY, Sun L, Vieweg J, et al
     Impact of nerve sparing technique on patient self-assessed outcomes after radical perineal prostatectomy.
     J Urol. 2007;178:488-92.
     PubMed     Related articles    Abstract available
     
     
     
130. LEE HY , Lee HJ, Byun SS, Lee SE, et al
     Effect of intraprostatic local anesthesia during transrectal ultrasound guided prostate biopsy: comparison of 3 methods in a randomized, double-blind, placebo controlled trial.
     J Urol. 2007;178:469-72.
     PubMed     Related articles    Abstract available
     
     
     July 2007
131. YE L , Lewis-Russell JM, Kynaston H, Jiang WG, et al
     Endogenous Bone Morphogenetic Protein-7 Controls the Motility of Prostate Cancer Cells Through Regulation of Bone Morphogenetic Protein Antagonists.
     J Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
132. 
     2006 Conference on Innovations and Challenges in Prostate Cancer.
     J Urol. 2007;.
     PubMed     Related articles   
     
     
     
133. COOPERBERG MR , Broering JM, Kantoff PW, Carroll PR, et al
     Contemporary Trends in Low Risk Prostate Cancer: Risk Assessment and Treatment.
     J Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
134. 
     2006 Conference on Innovations and Challenges in Prostate Cancer Earn up to 2.0 Complimentary CME AMA PRA Category 1 Creditstrade mark.
     J Urol. 2007;.
     PubMed     Related articles   
     
     
     
135. RYAN CJ , Beer TM
     Prostate Specific Antigen Only Androgen Independent Prostate Cancer: Natural History, Challenges in Management and Clinical Trial Design.
     J Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
136. GIGNAC GA , Morris MJ, Hussain M
     Castration Resistant, Taxane Naive Metastatic Prostate Cancer: Current Clinical Approaches and Future Directions.
     J Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
137. MATHEW P , Dipaola R
     Taxane Refractory Prostate Cancer.
     J Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
138. BRADLEY DA , Hussain M, Dipaola RS, Kantoff P, et al
     Bone Directed Therapies for Prostate Cancer.
     J Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
139. KANTOFF PW , Beer TM, D'Amico AV, Dipaola RS, et al
     Innovations and Challenges in Prostate Cancer: Summary Statement for the 6th Cambridge Conference.
     J Urol. 2007;.
     PubMed     Related articles   
     
     
     
140. THOMPSON IM
     Chemoprevention of Prostate Cancer: Agents and Study Designs.
     J Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
141. LATINI DM , Hart SL, Knight SJ, Cowan JE, et al
     The Relationship Between Anxiety and Time to Treatment for Patients With Prostate Cancer on Surveillance.
     J Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
142. VENKITARAMAN R , Norman A, Woode-Amissah R, Fisher C, et al
     Predictors of Histological Disease Progression in Untreated, Localized Prostate Cancer.
     J Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
143. COREY E , Vessella RL
     Bone Morphogenetic Proteins and Prostate Cancer: Evolving Complexities.
     J Urol. 2007;.
     PubMed     Related articles   
     
     
     
144. BOORJIAN SA , Thompson RH, Siddiqui S, Bagniewski S, et al
     Long-Term Outcome After Radical Prostatectomy for Patients With Lymph Node Positive Prostate Cancer in the Prostate Specific Antigen Era.
     J Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
145. CULINE S , El Demery M, Lamy PJ, Iborra F, et al
     Docetaxel and Cisplatin in Patients With Metastatic Androgen Independent Prostate Cancer and Circulating Neuroendocrine Markers.
     J Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
146. KOOPMANS N , de Jong IJ, Breeuwsma AJ, van der Veer E, et al
     Serum Bone Turnover Markers (PINP and ICTP) for the Early Detection of Bone Metastases in Patients With Prostate Cancer: A Longitudinal Approach.
     J Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
147. BERRUTI A , Mosca A, Porpiglia F, Bollito E, et al
     Chromogranin A Expression in Patients With Hormone Naive Prostate Cancer Predicts the Development of Hormone Refractory Disease.
     J Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
148. FREEMAN MR
     Beta2 microglobulin: a surprising therapeutic target for prostate cancer and renal cell carcinoma.
     J Urol. 2007;178:10-1.
     PubMed     Related articles   
     
     
     
149. XIAO Z , Dickey D, Owen RJ, Tulip J, et al
     Interstitial photodynamic therapy of the canine prostate using intra-arterial administration of photosensitizer and computerized pulsed light delivery.
     J Urol. 2007;178:308-13.
     PubMed     Related articles    Abstract available
     
     
     
150. NAMIKI S , Saito S, Nakagawa H, Sanada T, et al
     Impact of unilateral sural nerve graft on recovery of potency and continence following radical prostatectomy: 3-year longitudinal study.
     J Urol. 2007;178:212-6.
     PubMed     Related articles    Abstract available
     
     
     
151. YUN TJ , Lee HJ, Kim SH, Lee SE, et al
     Does the intrarectal instillation of lidocaine gel before periprostatic neurovascular bundle block during transrectal ultrasound guided prostate biopsies improve analgesic efficacy? A prospective, randomized trial.
     J Urol. 2007;178:103-6.
     PubMed     Related articles    Abstract available
     
     
     
152. KASSOUF W , Nakanishi H, Ochiai A, Babaian KN, et al
     Effect of prostate volume on tumor grade in patients undergoing radical prostatectomy in the era of extended prostatic biopsies.
     J Urol. 2007;178:111-4.
     PubMed     Related articles    Abstract available
     
     
     June 2007
153. KITAMURA H , Torigoe T, Asanuma H, Honma I, et al
     Down-Regulation of HLA Class I Antigens in Prostate Cancer Tissues and Up-Regulation by Histone Deacetylase Inhibition.
     J Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
154. BURNETT AL , Aus G, Canby-Hagino ED, Cookson MS, et al
     Erectile Function Outcome Reporting After Clinically Localized Prostate Cancer Treatment.
     J Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
155. ELLIOTT SP , Meng MV, Elkin EP, McAninch JW, et al
     Incidence of Urethral Stricture After Primary Treatment for Prostate Cancer: Data From CaPSURE.
     J Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
156. NAMIKI S , Takegami M, Kakehi Y, Suzukamo Y, et al
     Analysis Linking UCLA PCI With Expanded Prostate Cancer Index Composite: An Evaluation of Health Related Quality of Life in Japanese Men With Localized Prostate Cancer.
     J Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
157. YOSSEPOWITCH O , Eggener SE, Bianco FJ Jr, Carver BS, et al
     Radical Prostatectomy for Clinically Localized, High Risk Prostate Cancer: Critical Analysis of Risk Assessment Methods.
     J Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
158. THOMPSON RH , Blute ML, Slezak JM, Bergstralh EJ, et al
     Is the GPSM Scoring Algorithm for Patients With Prostate Cancer Valid in the Contemporary Era?
     J Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
159. WAGNER MD , Daneshmand S, Sokoloff M, Barry JM, et al
     Re: Prediagnosis Prostate Specific Antigen Velocity is Associated With Risk of Prostate Cancer Progression Following Brachytherapy and External Beam Radiation Therapy S. E. Eggener, K. A. Roehl, O. Yossepowitch and W. J. Catalona J Urol 2006; 176: 139
     J Urol. 2007;177:2396.
     PubMed     Related articles   
     
     
     
160. AHMED HU , Calleary J, Arya M, Emberton M, et al
     Re: dynamic contrast enhanced, pelvic phased array magnetic resonance imaging of localized prostate cancer for predicting tumor volume: correlation with radical prostatectomy findings a. Villers, p. Puech, d. Mouton, x. Leroy, C. Ballereau and L. Lema
     J Urol. 2007;177:2395.
     PubMed     Related articles   
     
     
     
161. SERFLING R , Shulman M, Thompson GL, Xiao Z, et al
     Quantifying the impact of prostate volumes, number of biopsy cores and 5alpha-reductase inhibitor therapy on the probability of prostate cancer detection using mathematical modeling.
     J Urol. 2007;177:2352-6.
     PubMed     Related articles    Abstract available
     
     
     
162. FRANK SJ , Pisters LL, Davis J, Lee AK, et al
     An assessment of quality of life following radical prostatectomy, high dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer.
     J Urol. 2007;177:2151-6.
     PubMed     Related articles    Abstract available
     
     
     
163. POMERANTZ M , Manola J, Taplin ME, Bubley G, et al
     Phase II Study of Low Dose and High Dose Conjugated Estrogen for Androgen Independent Prostate Cancer.
     J Urol. 2007;177:2146-50.
     PubMed     Related articles    Abstract available
     
     
     
164. KRAINER M , Tomek S, Elandt K, Horak P, et al
     A Prospective, Open Label, Randomized Phase II Trial of Weekly Docetaxel Versus Weekly Vinorelbine as First Line Chemotherapy in Patients With Androgen Independent Prostate Cancer.
     J Urol. 2007;177:2141-5.
     PubMed     Related articles    Abstract available
     
     
     
165. LORD R , Nair S, Schache A, Spicer J, et al
     Low Dose Metronomic Oral Cyclophosphamide for Hormone Resistant Prostate Cancer: A Phase II Study.
     J Urol. 2007;177:2136-2140.
     PubMed     Related articles    Abstract available
     
     
     
166. THOMPSON I , Thrasher JB, Aus G, Burnett AL, et al
     Guideline for the management of clinically localized prostate cancer: 2007 update.
     J Urol. 2007;177:2106-31.
     PubMed     Related articles   
     
     
     
167. PENSON DF , Chan JM
     Prostate cancer.
     J Urol. 2007;177:2020-9.
     PubMed     Related articles    Abstract available
     
     
     
168. RAMSEY SD , Zeliadt SB, Hall IJ, Ekwueme DU, et al
     On the importance of race, socioeconomic status and comorbidity when evaluating quality of life in men with prostate cancer.
     J Urol. 2007;177:1992-9.
     PubMed     Related articles    Abstract available
     
     
     
169. DE E , Pisters LL, Pettaway CA, Scott S, et al
     Salvage prostatectomy with bladder neck closure, continent catheterizable stoma and bladder augmentation: feasibility and patient reported continence outcomes at 32 months.
     J Urol. 2007;177:2200-4.
     PubMed     Related articles    Abstract available
     
     
     
170. PATHAK AS , Pacificar JS, Shapiro CE, Williams SG, et al
     Determining dosing intervals for luteinizing hormone releasing hormone agonists based on serum testosterone levels: a prospective study.
     J Urol. 2007;177:2132-5.
     PubMed     Related articles    Abstract available
     
     
     
171. FREEDLAND SJ , Moul JW
     Prostate specific antigen recurrence after definitive therapy.
     J Urol. 2007;177:1985-91.
     PubMed     Related articles    Abstract available
     
     
     
172. KIBEL AS
     Optimizing prostate biopsy techniques.
     J Urol. 2007;177:1976-7.
     PubMed     Related articles   
     
     
     May 2007
173. VALE S
     Re: Expression of Major Heat Shock Proteins in Prostate Cancer: Correlation With Clinicopathological Outcomes in Patients Undergoing Radical Prostatectomy T. Kurahashi, H. Miyake, I. Hara and M. Fujisawa J Urol 2007; 177: 757-761.
     J Urol. 2007;.
     PubMed     Related articles   
     
     
     
174. WALZ J , Perrotte P, Gallina A, Benard F, et al
     Ejaculatory Disorders May Affect Screening for Prostate Cancer.
     J Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
175. GRAIF T , Loeb S, Roehl KA, Gashti SN, et al
     Under Diagnosis and Over Diagnosis of Prostate Cancer.
     J Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
176. TOUIJER K , Rabbani F, Otero JR, Secin FP, et al
     Standard vs Limited Pelvic Lymph Node Dissection for Prostate Cancer in Patients With a Predicted Probability of Nodal Metastasis Greater Than 1%
     J Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
177. ABRAHAM N , Wan F, Montagnet C, Wong YN, et al
     Decrease in Racial Disparities in the Staging Evaluation for Prostate Cancer After Publication of Staging Guidelines.
     J Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
178. WARREN KS , McFarlane JP
     Is Routine Digital Rectal Examination Required for the Followup of Prostate Cancer?
     J Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
179. PELZER AE , Bektic J, Akkad T, Ongarello S, et al
     Under Diagnosis and Over Diagnosis of Prostate Cancer in a Screening Population With Serum PSA 2 to 10 ng/ml.
     J Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
180. CLARKE MG , Wilson JR, Kennedy KP, Macdonagh RP, et al
     Clinical Judgment Analysis of the Parameters Used by Consultant Urologists in the Management of Prostate Cancer.
     J Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
181. THOMPSON IM , Lucia MS, Redman MW, Darke A, et al
     Finasteride Decreases the Risk of Prostatic Intraepithelial Neoplasia.
     J Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
182. LANE TM , Strefford JC, Yanez-Munoz RJ, Purkis P, et al
     Identification of a Recurrent t(4;6) Chromosomal Translocation in Prostate Cancer.
     J Urol. 2007;177:1907-1912.
     PubMed     Related articles    Abstract available
     
     
     
183. KAKEHI Y , Takegami M, Suzukamo Y, Namiki S, et al
     Health related quality of life in Japanese men with localized prostate cancer treated with current multiple modalities assessed by a newly developed Japanese version of the expanded prostate cancer index composite.
     J Urol. 2007;177:1856-61.
     PubMed     Related articles    Abstract available
     
     
     
184. DEIBERT CM , Maliski S, Kwan L, Fink A, et al
     Prostate cancer knowledge among low income minority men.
     J Urol. 2007;177:1851-5.
     PubMed     Related articles    Abstract available
     
     
     
185. KIBEL AS , Rosenbaum E, Kattan MW, Picus J, et al
     Adjuvant weekly docetaxel for patients with high risk prostate cancer after radical prostatectomy: a multi-institutional pilot study.
     J Urol. 2007;177:1777-81.
     PubMed     Related articles    Abstract available
     
     
     
186. COTTRELL S , Jung K, Kristiansen G, Eltze E, et al
     Discovery and validation of 3 novel DNA methylation markers of prostate cancer prognosis.
     J Urol. 2007;177:1753-8.
     PubMed     Related articles    Abstract available
     
     
     
187. THOMPSON IM , Tangen CM, Goodman PJ, Lucia MS, et al
     Finasteride improves the sensitivity of digital rectal examination for prostate cancer detection.
     J Urol. 2007;177:1749-52.
     PubMed     Related articles    Abstract available
     
     
     
188. LOEB S , Nadler RB, Roehl KA, Antenor JA, et al
     Risk of prostate cancer for young men with a prostate specific antigen less than their age specific median.
     J Urol. 2007;177:1745-8.
     PubMed     Related articles    Abstract available
     
     
     
189. BRUNO JJ 2ND , Armenakas NA, Fracchia JA
     Influence of Prostate Volume and Percent Free Prostate Specific Antigen on Prostate Cancer Detection in Men With a Total Prostate Specific Antigen of 2.6 to 10.0 ng/ml.
     J Urol. 2007;177:1741-4.
     PubMed     Related articles    Abstract available
     
     
     
190. HANSEL DE , Demarzo AM, Platz EA, Jadallah S, et al
     Early prostate cancer antigen expression in predicting presence of prostate cancer in men with histologically negative biopsies.
     J Urol. 2007;177:1736-40.
     PubMed     Related articles    Abstract available
     
     
     
191. DALL'ERA M , Carroll PR
     Prostate cancer-more information and more questions.
     J Urol. 2007;177:1607-8.
     PubMed     Related articles   
     
     
     
192. ANAI S , Tanaka M, Shiverick KT, Kim W, et al
     Increased expression of cyclooxygenase-2 correlates with resistance to radiation in human prostate adenocarcinoma cells.
     J Urol. 2007;177:1913-7.
     PubMed     Related articles    Abstract available
     
     
     
193. ATES M , Teber D, Gozen AS, Tefekli A, et al
     Do tumor volume, tumor volume ratio, type of nerve sparing and surgical experience affect prostate specific antigen recurrence after laparoscopic radical prostatectomy? A matched pair analysis.
     J Urol. 2007;177:1771-5.
     PubMed     Related articles    Abstract available
     
     
     
194. RODRIGUEZ AR , Kapoor R, Pow-Sang JM
     Laparoscopic extraperitoneal radical prostatectomy in complex surgical cases.
     J Urol. 2007;177:1765-70.
     PubMed     Related articles    Abstract available
     
     
     
195. STONE NN , Stock RG, White I, Unger P, et al
     Patterns of local failure following prostate brachytherapy.
     J Urol. 2007;177:1759-63.
     PubMed     Related articles    Abstract available
     
     
     April 2007
196. BRU A
     Re: Clinical and immunological characteristics of patients with serologic progression of prostate cancer achieving long-term disease control with granulocyte-macrophage colony-stimulating factor: B. I. Rini, L. Fong, v. Weinberg, B. Kavanaugh and E. J
     J Urol. 2007;177:1585.
     PubMed     Related articles   
     
     
     
197. GILBERT SM , Dunn RL, Wei JT
     Re: Zoledronic acid initiated during the first year of androgen deprivation therapy increases bone mineral density in patients with prostate cancer: C. W. Ryan, D. Huo, L. M. Demers, T. M. Beer and L. V. Lacerna. J Urol 2006; 176: 972-978.
     J Urol. 2007;177:1584-5.
     PubMed     Related articles   
     
     
     
198. KRISTAL AR , Arnold KB, Schenk JM, Neuhouser ML, et al
     Race/ethnicity, obesity, health related behaviors and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial.
     J Urol. 2007;177:1395-400.
     PubMed     Related articles    Abstract available
     
     
     
199. FUKUDA M , Egawa M, Imao T, Takashima H, et al
     Detection of sentinel node micrometastasis by step section and immunohistochemistry in patients with prostate cancer.
     J Urol. 2007;177:1313-7.
     PubMed     Related articles    Abstract available
     
     
     
200. GRAFF JN , Mori M, Li H, Garzotto M, et al
     Predictors of overall and cancer-free survival of patients with localized prostate cancer treated with primary androgen suppression therapy: results from the prostate cancer outcomes study.
     J Urol. 2007;177:1307-12.
     PubMed     Related articles    Abstract available
     
     
     
201. WALSH RM , Thompson IM
     Prostate cancer screening and disease management: how screening may have an unintended effect on survival and mortality-the camel's nose effect.
     J Urol. 2007;177:1303-6.
     PubMed     Related articles    Abstract available
     
     
     
202. FLAIG TW , Nordeen SK, Lucia MS, Harrison GS, et al
     Conference report and review: current status of biomarkers potentially associated with prostate cancer outcomes.
     J Urol. 2007;177:1229-37.
     PubMed     Related articles    Abstract available
     
     
     
203. HUANG WC , Kuroiwa K, Serio AM, Bianco FJ Jr, et al
     The anatomical and pathological characteristics of irradiated prostate cancers may influence the oncological efficacy of salvage ablative therapies.
     J Urol. 2007;177:1324-9.
     PubMed     Related articles    Abstract available
     
     
     
204. YU X , Loeb S, Roehl KA, Han M, et al
     The association between total prostate specific antigen concentration and prostate specific antigen velocity.
     J Urol. 2007;177:1298-302.
     PubMed     Related articles    Abstract available
     
     
     
205. BENSON MC , McKiernan J
     Prostate specific antigen screening.
     J Urol. 2007;177:1225-6.
     PubMed     Related articles   
     
     
     March 2007
206. ZHANG J , Lipinski R, Shaw A, Gipp J, et al
     Lack of demonstrable autocrine hedgehog signaling in human prostate cancer cell lines.
     J Urol. 2007;177:1179-85.
     PubMed     Related articles    Abstract available
     
     
     
207. ALBERTSEN PC , Hanley JA, Penson DF, Barrows G, et al
     13-year outcomes following treatment for clinically localized prostate cancer in a population based cohort.
     J Urol. 2007;177:932-6.
     PubMed     Related articles    Abstract available
     
     
     
208. FAMILI P , Cauley JA, Greenspan SL
     The effect of androgen deprivation therapy on periodontal disease in men with prostate cancer.
     J Urol. 2007;177:921-4.
     PubMed     Related articles    Abstract available
     
     
     
209. WECKERMANN D , Dorn R, Trefz M, Wagner T, et al
     Sentinel lymph node dissection for prostate cancer: experience with more than 1,000 patients.
     J Urol. 2007;177:916-20.
     PubMed     Related articles    Abstract available
     
     
     
210. TEWARI A , Divine G, Chang P, Shemtov MM, et al
     Long-term survival in men with high grade prostate cancer: a comparison between conservative treatment, radiation therapy and radical prostatectomy-a propensity scoring approach.
     J Urol. 2007;177:911-5.
     PubMed     Related articles    Abstract available
     
     
     
211. LOEB S , Roehl KA, Catalona WJ, Nadler RB, et al
     Prostate specific antigen velocity threshold for predicting prostate cancer in young men.
     J Urol. 2007;177:899-902.
     PubMed     Related articles    Abstract available
     
     
     
212. LIU X , Cicek MS, Plummer SJ, Jorgenson E, et al
     Association of testis derived transcript gene variants and prostate cancer risk.
     J Urol. 2007;177:894-8.
     PubMed     Related articles    Abstract available
     
     
     
213. BOORJIAN S , Cowan JE, Konety BR, Duchane J, et al
     Bladder cancer incidence and risk factors in men with prostate cancer: results from cancer of the prostate strategic urologic research endeavor.
     J Urol. 2007;177:883-8.
     PubMed     Related articles    Abstract available
     
     
     
214. DOBOSY JR , Roberts JL, Fu VX, Jarrard DF, et al
     The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia.
     J Urol. 2007;177:822-31.
     PubMed     Related articles    Abstract available
     
     
     
215. NELSON B , Kaufman M, Broughton G, Cookson MS, et al
     Comparison of length of hospital stay between radical retropubic prostatectomy and robotic assisted laparoscopic prostatectomy.
     J Urol. 2007;177:929-31.
     PubMed     Related articles    Abstract available
     
     
     
216. STONE NN , Stock RG
     The effect of brachytherapy, external beam irradiation and hormonal therapy on prostate volume.
     J Urol. 2007;177:925-8.